Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
289 GBX | +4.52% | +34.42% | +31.36% |
04-29 | FTSE 100 as investors look to Fed rate decision | AN |
04-29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.36% | 346M | |
-2.56% | 102B | |
+2.50% | 96.09B | |
+2.13% | 22.28B | |
-17.03% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-14.01% | 16.09B | |
+6.30% | 13.83B | |
+32.14% | 11.97B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc Signs Supply Agreement with AstraZeneca UK Ltd